Joseph Hulihan, MD, MSHP, brings substantial clinical development experience advancing novel therapies for TSC-related ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into ...

Delta 8 gummies have quickly become one of the most popular cannabis-derived products in the wellness market. Known for ...

GAAP net loss increased to $26.7 million in Q2 2025, driven by higher research and development spending and public company costs. The RAP-219 Phase 2a epilepsy trial is fully enrolled and remains on ...

Guidance for full-year 2025 product revenue and adjusted EBITDA was increased as prescription growth from ADHD drug Jornay PM accelerates, with prescriptions up 23% year-over-year. These 10 stocks ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

"In the summer, hot weather and increased social drinking can lead to dehydration. Medical studies have shown that this ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Discontinuation rates in pediatric trials remain high, reflecting logistical and clinical obstacles. To overcome these hurdles, clinical research organizations can assist - re-thinking pediatric trial ...

Christina Applegate, battling multiple sclerosis, was hospitalized in Los Angeles due to a severe kidney infection that ...

In a revolutionary study, Harvard and Rush University researchers discovered a key that may unlock multiple hidden mysteries ...